Cargando…

Biomarkers for systemic lupus erythematosus: has the right time finally arrived?

Detalles Bibliográficos
Autor principal:	Mittleman, Barbara B
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC546276/ https://www.ncbi.nlm.nih.gov/pubmed/15380037 http://dx.doi.org/10.1186/ar1186

Ejemplares similares

Using a bedside test to detect genetic susceptibility to aminoglycoside‐induced hearing loss: Has the future arrived?
por: May, Meryta L, et al.
Publicado: (2022)

Immunotherapy for Lung Cancer: Has it Finally Arrived?
por: Mostafa, Ahmed A., et al.
Publicado: (2014)

Learning from incidents in healthcare: the journey, not the arrival, matters
por: Leistikow, Ian, et al.
Publicado: (2017)

From ambivalent to divalent: Has the “zinc age” finally arrived?
por: Crane, John K
Publicado: (2013)

The Late Arrival of Coronavirus Disease 2019 (COVID-19) in Africa: Mitigating Pan-continental Spread
por: Nachega, Jean, et al.
Publicado: (2020)

PReS-FINAL-2299: Novel biomarkers for the assessment of pediatric systemic lupus erythematosus nephritis (preliminary report)
por: Koutsonikoli, A, et al.
Publicado: (2013)

Time poverty: Obstacle to women’s human rights, health and sustainable development
por: Hyde, Elizabeth, et al.
Publicado: (2020)

‘Injury prevention versus performance’: has the time come to mandate the use of mouthguards in all contact sports?
por: Ahmed, Irfan, et al.
Publicado: (2021)

Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus
por: Stypińska, Barbara, et al.
Publicado: (2015)

Upholding Human Rights in the Wake of COVID-19: Time to Strengthen Pharmaceutical Accountability
por: Turkie, Rosalind
Publicado: (2022)

High mortality due to snakebites in French Guiana: Time has come to re-evaluate medical management protocols
por: Mutricy, Rémi, et al.
Publicado: (2018)

Has the time come for regional periprosthetic joint infection centers in the United States? A first-year experience
por: Adrados, Murillo, et al.
Publicado: (2022)

Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus
por: Perez-Hernandez, Javier, et al.
Publicado: (2015)

Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus
por: Yu, Haitao, et al.
Publicado: (2021)

Complement as a Biomarker for Systemic Lupus Erythematosus
por: Ayano, Masahiro, et al.
Publicado: (2023)

COVID-19 has exposed the need for health system assessments to be more child health-sensitive
por: Jansen, Danielle EMC, et al.
Publicado: (2022)

COVID-19 and Cybersecurity: Finally, an Opportunity to Disrupt?
por: Ferreira, Ana, et al.
Publicado: (2021)

Polyethylene glycol and bisacodyl for colonoscopy: has the time arrived?
por: Hassan, Cesare, et al.
Publicado: (2013)

Diagnosing Periprosthetic Joint Infection: Has the Era of the Biomarker Arrived?
por: Deirmengian, Carl, et al.
Publicado: (2014)

PReS-FINAL-2352: Apoptosis profile in patients with juvenile-onset systemic lupus erythematosus
por: Liphaus, B, et al.
Publicado: (2013)

Deworming and Development: Asking the Right Questions, Asking the Questions Right
por: Bundy, Donald A. P., et al.
Publicado: (2009)

PReS-FINAL-2292: Hypogonadism and osteoporosis among adolescents with systemic lupus erythematosus
por: El-Ghoneimy, D, et al.
Publicado: (2013)

Has the NTD Community Neglected Evidence-Based Policy?
por: Nagpal, Sukrti, et al.
Publicado: (2013)

Has Your Physician Heard of Williams-Beuren Syndrome?
por: Alquran, Lance, et al.
Publicado: (2020)

The Era of Telehealth Has Arrived
por: Stanton, Bonita F.
Publicado: (2020)

Synthetic nicotine has arrived
por: Jordt, Sven-Eric
Publicado: (2023)

Removing Educational Achievement Points From the Foundation Programme Application System: Is This the Right Decision?
por: Ganesh Kumar, Abirami, et al.
Publicado: (2021)

Oxidative stress and its biomarkers in systemic lupus erythematosus
por: Shah, Dilip, et al.
Publicado: (2014)

Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus
por: Zhang, Qiong, et al.
Publicado: (2019)

Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus
por: Nakayamada, Shingo, et al.
Publicado: (2023)

Undertesting of COVID-19 in Indonesia: what has gone wrong?
por: van Empel, Giovanni, et al.
Publicado: (2020)

Working in Venezuela: How the Crisis has Affected the Labor Conditions
por: Caraballo-Arias, Yohama, et al.
Publicado: (2018)

How the COVID-19 pandemic has affected rheumatology research
por: Moreyra, Paula Alba, et al.
Publicado: (2022)

UN resolution on the elimination of harmful practices and the protection of human rights of mothers impacted by albinism
por: Reimer-Kirkham, Sheryl, et al.
Publicado: (2022)

The global battle for sexual rights
por: Altman, Dennis, et al.
Publicado: (2014)

Is the right to health compatible with sustainability?
por: Reidpath, Daniel D, et al.
Publicado: (2015)

Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis
por: Xue, Jing, et al.
Publicado: (2017)

The importance of implementing proper selection of excipients in lupus clinical trials
por: Muller, S, et al.
Publicado: (2014)

PReS-FINAL-2353: Are rasopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus?
por: Bader-Meunier, B, et al.
Publicado: (2013)

PReS-FINAL-2293: An attempt to analyze variants of systemic lupus erythematosus onsets in childhood
por: Kuchinskaya, E, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k5qcmkk195g177eqvaacg7n8k9